Kevin Ho is a Director, Business Development & Acquisitions at AbbVie, whose known portfolio counts 16 companies.
Is Kevin Ho a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Director, Business Development & Acquisitions at AbbVie, whose known portfolio counts 16 companies
- Zag Bio
- Carisma Therapeutics
- Third Arc Bio
- Accent Therapeutics
- DISCO Pharmaceuticals
- Jnana Therapeutics
- Oisin Biotechnologies
- Soufflé Therapeutics
- Syndeio Biosciences
- Light Horse Therapeutics
- BaseLaunch
- Cephagenix
- and 4 more
Investor Profile
Kevin Ho is listed against sector Healthcare, and focus areas Biotech, Cell & Gene, Drug Discovery and Genomics in the database.
AbbVie appears in Growth, Seed and Series A rounds across its known deals.
The firm portfolio and the focus above give founders context on whether Kevin Ho matches their raise.
Colleagues at AbbVie
Michael Widmann
Associate Director, Portfolio Strategy & Analytics
Chicago, United States
Mayara Doile
Senior Executive
São Paulo, Brazil
Wenwen He
Venture Capital
United States
Tatiana W
Investor & Partner
United States
Christine Hsieh
Venture Partner
Boston, United States
Andrew Little
Investor
Boston, United States
Doug Faunce
Executive Director
Irvine, United States
Keith Hamel
Director
Chicago, United States
Frequently asked questions
Who is Kevin Ho?
Kevin Ho is a corporate venture investor based in San Francisco, California, United States, listed as Director, Business Development & Acquisitions at AbbVie. The known portfolio of that firm counts 16 companies. That portfolio belongs to the firm, not to Kevin Ho personally.
What does Kevin Ho invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Cell & Gene, Drug Discovery and Genomics. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Kevin Ho invest at?
AbbVie appears in Growth, Seed and Series A rounds across its known deals, and Kevin Ho is listed there as Director, Business Development & Acquisitions. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Kevin Ho listed at?
Kevin Ho is listed as Director, Business Development & Acquisitions at AbbVie. 8 other people in the database share a firm with Kevin Ho.
How do I contact Kevin Ho?
An email address and a LinkedIn page are on file for Kevin Ho. The address stays masked on this page and is readable inside RaiseHunt after you create an account. The database holds no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal